IN RE: NORDT DEVELOPMENT CO., LLC
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Moore, Taranto, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: In a product-by-process claim, terms that can be equally understood as structural or process limitations should generally be construed as structural limitations.
The claims at issue refer to “injection molded” components of a knee brace. The Examiner afforded the term “injection molded” no patentable weight after construing the claims as product-by-process claims and the term as a process limitation. As a result, the Examiner rejected the claims as anticipated. The Board affirmed and Nordt appealed to the Federal Circuit.
The Federal Circuit held that the term “injection molded” is structural and should have been afforded patentable weight. Although the application describes “injection molded” as a process of manufacture, there were “clear structural differences” between a knee brace made with fabric components and injection-molded components. Moreover, terms that can equally be understood as structural or process limitations are “commonly and by default interpreted in their structural sense, unless the patentee has demonstrated otherwise.” Thus, the Federal Circuit vacated the anticipation rejection and remanded.
This case is: IN RE: NORDT DEVELOPMENT CO., LLC
Written By: Adam Powell and Josepher Li
Edited By: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…